ReviewBiology2022

Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

Hyunjung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.